PharmaVOICE Woman of the Week: Sheila Mathias, Ph.D.
Chief Scientific Officer Virpax Pharmaceuticals November 17, 2021
Dr. Sheila Mathias, Chief Scientific Officer of Virpax Pharmaceuticals, has an extensive set of complimentary skills that have her positioned perfectly to lead the biotech company to its next phase of success.
PAINWeek 2021 - Enkephalin as a Potential Analgesic and CNS Modulator
The following poster from Virpax will be presented on Thursday, September 9th from 6:30 p.m. – 8:30 p.m. PST: Title: Enkephalin as a Potential Analgesic and CNS Modulator Presenter: Jeffrey A. Gudin, MD, EVP, Chief Medical Officer of Virpax Pharmaceuticals Abstract ID: 1090715 Poster No. :29
